532815 Stock Overview
Manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
SMS Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹259.30 |
| 52 Week High | ₹398.00 |
| 52 Week Low | ₹175.00 |
| Beta | 0.91 |
| 1 Month Change | 19.71% |
| 3 Month Change | 39.75% |
| 1 Year Change | 26.06% |
| 3 Year Change | 199.77% |
| 5 Year Change | 585.07% |
| Change since IPO | 624.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532815 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 5.7% | 2.7% | 6.3% |
| 1Y | 26.1% | 12.1% | 4.0% |
Return vs Industry: 532815 exceeded the Indian Pharmaceuticals industry which returned 12.1% over the past year.
Return vs Market: 532815 exceeded the Indian Market which returned 4% over the past year.
Price Volatility
| 532815 volatility | |
|---|---|
| 532815 Average Weekly Movement | 8.1% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in IN Market | 9.8% |
| 10% least volatile stocks in IN Market | 4.7% |
Stable Share Price: 532815 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 532815's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 1,197 | Ramesh Potluri | smspharma.com |
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. The company offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides.
SMS Pharmaceuticals Limited Fundamentals Summary
| 532815 fundamental statistics | |
|---|---|
| Market cap | ₹22.99b |
| Earnings (TTM) | ₹660.99m |
| Revenue (TTM) | ₹7.80b |
34.8x
P/E Ratio2.9x
P/S RatioIs 532815 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532815 income statement (TTM) | |
|---|---|
| Revenue | ₹7.80b |
| Cost of Revenue | ₹5.33b |
| Gross Profit | ₹2.47b |
| Other Expenses | ₹1.81b |
| Earnings | ₹660.99m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.46 |
| Gross Margin | 31.66% |
| Net Profit Margin | 8.47% |
| Debt/Equity Ratio | 50.6% |
How did 532815 perform over the long term?
See historical performance and comparisonDividends
0.2%
Current Dividend Yield6%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/19 11:03 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
SMS Pharmaceuticals Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anil Burra | FirstCall Research |